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Super disintegrantsAbstract The SeDeM expert system is a pre formulation tool applied for the prediction of the suit-
ability of a material for direct compression. This innovative tool provides an index of good com-
pressibility of the material indicating its aptitude to be compressed by direct compression. In the
study the SeDeM expert system has been applied for the prediction of the behavior of the material
to be used in the formulation of effervescent tablets by direct compression. Different formulations
were developed on the basis of the results of the SeDeM expert system.
Various parameters for the material as per the SeDeM expert system were determined according
to their ofﬁcial and reported methods. Powder blend for different formulations was evaluated for
their rheological properties while tablets were evaluated for various ofﬁcial and unofﬁcial tests.
Suitability of the material for direct compression was successfully predicted using the SeDeM
expert system. Domperidone was found unsuitable for direct compression. During formulation
all excipients responded as they were predicted as per the SeDeM expert system. Tablets produced
using the resultant formulations were having sufﬁcient mechanical strength, free of premature effer-
vescence and were capable to be scaled up for commercial manufacturing.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
SeDeM expert system is a pre formulation methodology ap-
plied for the formulation development of solid dosage form
(Tablets) by direct compression (Pilar et al., 2006). Quality
by design ICH-Q8 provides a basis for the SeDeM expert sys-
tem. It is used for an evaluation of critical quality attributes
having an impact on the ﬁnal product. This system provides
a physical proﬁle of A.P.I. and excipients intended to be used
434 A. Khan et al.and suggests their suitability for direct compression (Johnny
et al., 2009). It also points out parameters needing to be im-
proved to get a formulation that can be successfully processed
by direct compression i.e., the proﬁle of powder shows its
advantages and gaps for their suitability for direct compres-
sion (Pilar et al., 2006; Inderbir and Pradeep, 2012).
The SeDeM expert system also calculates the amount of
excipients with certain characteristics required for correction
of a particular property in order to make the ﬁnal blend suit-
able for direct compression. Several parameters have been se-
lected that must be fulﬁlled by the formulation to ensure
successful and robust processing by direct compression tech-
nology (Johnny et al., 2012; Josep et al., 2008).
Effervescent tablets are a promising dosage form combin-
ing qualities of both solid and liquid dosage forms. These
are dissolved or dispersed in water before administration and
taken as liquid thus presenting the drug in a palatable liquid
form while retaining the properties of a solid dosage form like
easy portability, high stability and accurate dose (British Phar-
macopoeias, 2008). pH of the liquid formed after effervescence
reaction can be controlled in the desired range by a proper
selection of the quantities of acids and base. Furthermore, as
the drug is administered as a liquid, the whole of it is made
available for absorption from GIT (Ashutosh et al., 2008; Har-
ald, 2003).
The main problem with effervescent tablets is their chemical
instability exhibited by the premature effervescent reaction.
Even trace amounts of the water can initiate the self propagat-
ing reaction that continues till the consumption of the whole of
the acid and/or base resulting in a complete deterioration of
the product (Harald, 2003). Therefore the process of prepara-
tion should be carried out in an environment of controlled
humidity with a reduced number of steps to minimize material
exposure. The method of direct compression is desirable for
the preparation of effervescent tablets (Robert, 2001; Yuhua
and Diana, 2009) as it involves fewer steps and less material
handling and exposure (Harald, 2003). Main problem with
the direct compression method is the prediction of material
ﬂow and compressibility. Most of the APIs lack sufﬁcient ﬂow
and compressibility and requires selecting proper excipients for
their formulation by direct compression. A large number of tri-
als should be carried out to obtain formulations with proper
rheological properties and compressibility. This makes the
process more tedious, time consuming and a lot of material
is utilized. The SeDeM expert system can overcome the prob-
lem as it develops a database for excipients and an easy selec-
tion can be made without extra trials.
The SeDeM expert system has been applied for the predic-
tion of the suitability of different material used in the formula-
tion of effervescent tablets by direct compression. The results
predicted by the SeDeM expert system have been conﬁrmed
by an analysis of trials of the different formulations.
Various formulations were developed containing the effer-
vescent pair alone and in combination with super disinte-
grants. Effects of super disintegrant, tablet compression force
and tablet surface area have been evaluated.
Domperidone (5-chloro-1-h1-(3-(2,3-dihydro-2-oxo-1H-
benzimidazol-1-yl) propyl)-4-piperidinyl-1,3-dihydro-2H-ben-
zimidazol-2-one) was selected as a model drug. It is a dopa-
mine-receptor antagonist acting peripherally, having no
central effects with the elimination half life of 5–7 h (David
et al., 1998). According to bio pharmaceutical classiﬁcationsystem, domperidone has been classiﬁed as a class 2 drug. It
is a weak base having a good solubility at lower pH (Nagarsen-
ker et al., 2000). It absorbs well when the whole of the drug is
available for absorption in the acidic segment of G.I.T. This
can be made possible by administering domperidone as an
effervescent tablet.2. Materials and methods
2.1. Material
Domperidone (Ningbo Sansheng Pharmaceuticals Company,
China) was purchased fromMedicraft pharmaceuticals, Pesha-
war. Citric acid anhydrous, tartaric acid and sodium bicarbon-
ate (Merck KGA, Germany) were purchased from sigma
chemicals, Karachi. Rest of the excipients (Micro crystalline
cellulose (F.M.C. Bio polymers, Ireland), Tablettose (Molkerei
Meggle, Germany) and Magnesium stearate (Peter Greven,
Malaysia) were a kind gift from Ferozsons Laboratories,
Ltd., Nowshera. All the materials were of pharmaceutical
grade.
2.2. Methods
2.2.1. Evaluation of material as per SeDeM expert system
Powder material was evaluated for different parameters
according to the SeDeM expert system to determine their suit-
ability for direct compression. Some of them were determined
experimentally according to the established procedure and
some were calculated from experimental values of other
parameters (Pilar et al., 2006) as per Table 1.
2.2.2. Determination of basic parameters
The basic parameters of the SeDeM expert system are given as;
 Bulk density
 Tapped density
 Interparticle porosity
 Carr’s index
 Cohesion index
 Hausner ratio
 Angle of repose
 Powder ﬂow
 Loss on drying
 Hygroscopicity
 Particle size smaller than 50 lm
 Homogeneity index
2.2.3. Conversion of experimental values (V) to radius value (r)
of SeDeM diagram
The numerical values for different parameters of the material
obtained by experimental determination were converted into a
radius value (r) of the SeDeM expert system diagram. For the
conversion of experimental value of each parameter, speciﬁc fac-
tors were applied (Johnny et al., 2009) as listed in Table 1.
2.2.4. Graphical presentation of SeDeM diagram
SeDeM diagram was built up on the basis of 12 parameters
looking as 12 sided polygon (Johnny et al., 2009). Results
Table 1 All parameters of SeDeM expert system.
Factor/incidence Parameter Symbol Unit Equation Limits Applied factor
Dimension Bulk density Da g/ml Da = P/Va 0–1 10 V
Tapped density Dc g/ml Dc = P/Vc 0–1 10 V
Compressibility Inter particle porosity Ie 0 Dc–Da/Dc · Da 0–1.2 10 V/1.2
Carr’ index Ic % 100x(Dc–Da)/Dc 0–50 V/5
Cohesion Index Icd N Experimental 0–200 V/20
Flow ability/powder ﬂow Hausner ratio IH – Dc/Da 3–1 (30–10 V)/2
Angle of repose (a) 0 tan1(h/r) 0–50 10–(V/5)
Powder ﬂow t00 S Experimental 0–20 10–(V/2)
Lubricity/stability Loss on drying %HR % Experimental 0–10 10–V
Hygroscopicity %H % Experimental 0–20 10–(V/2)
Lubricity/dosage Particles < 50 %Pf % Experimental 0–50 10–(V/5)
Homogeneity index Ih – Fm/100 + DFmn 0–2 · 102 500 V
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parameters were converted and presented as a SeDeM diagram
as shown in Fig. 1.
2.2.5. Calculation of I.G.C.
For determination of suitability of the material for direct com-
pression the following indices are calculated on the basis of the
SeDeM system as below (Johnny et al., 2012).
2.2.6. Parameter index
I:P: ¼ No: PP 5
No: Pt
ð1Þ
where
No. PP 5 = parameters with values equal to or more than
5.
No. Pt = Total number of parameters.
Acceptability limit corresponds to a score of 5.Figure 1 Blank SeDeM diagram. Da, bulk density; Dc, tapped
density; Ie, inter-particle porosity; IC, Carr index; ICd, cohesion
index; IH, Hausner ratio; a, angle of repose; t00, ﬂow ability; %HR,
loss on drying; %H, Hygroscopicity; %Pf, Particle size; Ih,
Homogeneity index.2.2.7. Parameter proﬁle index
I.P.P. = Average of r value of all parameters
The acceptable limit corresponds to a score of 5.
2.2.8. Good Compressibility Index
I:G:C: ¼ I:P:P:  f ð2Þ
where
f= reliability factor.
2.2.9. Selection of acid to base ratio
Acid to base ratio of the effervescent pair was determined on
the basis of stichometric calculations of balanced acid and base
neutralization reaction. Calculated amount of acid and base
were added to 250 ml of water having pH 7 at ambient temper-
ature. After completion of acid base reaction, the pH of the
solution was determined to observe any remaining acid or
base.
2.2.10. Determination of per tablet quantity of effervescent pair
Placebo tablets were prepared with the same excipients and
same compression weight having varying degrees of efferves-
cent components. Three levels were studied for both acids sep-
arately. These were:
10% w/w
20% w/w
30% w/w
Compressed placebo tablets were subjected to an evaluation
for effervescence time using 250 ml of puriﬁed water with pH 7
at ambient temperature. An average of 6 determinations of
effervescence time was taken as the effervescence time of the
combination. Results were presented as average ± S.D.
2.2.11. Taste evaluation of tablets
For taste evaluation placebo tablets were prepared containing
taste making agent in different concentrations (1% w/w, 2%
w/w, 3% w/w, 4% w/w and 5% w/w) as shown in Table 2.
Taste making agent consisted of a ﬁxed quantity of ﬂavor (tutti
Table 2 Formulations of placebo tablets for taste evaluation.
Ingredients TEE-01 TEE-02 TEE-03 TEE-04 TEE-05 TEE-06
Micro crystalline cellulose 22 22 22 22 22 22
Tablettose-80 51 49 48 48.5 47.5 46.5
Citric acid anhydrous 10 10 10 10 10 10
Sodium bicarbonate 10 10 10 10 10 10
Flavor 0 0.5 0.5 0.5 0.5 0.5
Aspartame 0 1 2 3 4 5
Colloidal silicon dioxide 1 1 1 1 1 1
Magnesium stearate 1.5 1.5 1.5 1.5 1.5 1.5
C.C. Sodium 2.5 2.5 2.5 2.5 2.5 2.5
S.S. Glycolate 2.5 2.5 2.5 2.5 2.5 2.5
Quantities are given as % w/w.
436 A. Khan et al.fruity 0.5%) and sweetener (aspartame) making the remaining
quantity. Tablets were dispersed and their taste was evaluated
by a panel of 8 healthy human volunteers (30–45 years) having
one hour as the washout time between two determinations.
Observations of each volunteer were recorded on a scale rang-
ing from tasteless to better tasting.
2.2.12. Tablet preparation
The method of direct compression was applied for tablet prep-
aration. All materials were weighed accurately according to
their respective formulations as presented in Table 3. They
were sifted through a stainless steel mesh with a pore size of
0.85 mm (Endicott, England) and were blended in a laboratory
scale double cone mixer for 15 min at 20 rpm.
Tablets were prepared by compressing powder blend using
rotary compression machine D3A (Manesty, England) ﬁtted
with round ﬂat 13 mm round punches having bisection line.
Theoretical weight per tablet was 600 mg and 200 tablets were
compressed for each formulation. The whole of the processing
was carried out under the controlled conditions of humidity
(relative humidity below 35%).
2.2.13. Evaluation of powder blend
Prior to compression, the powder blend was evaluated for their
ﬂow and compressibility. Various parameters related to theTable 3 Formulations of effervescent domperidone tablets.
Ingredients ED-01 ED-02 ED-03 ED-04 ED-05 E
Domperidone 1.67 1.67 1.67 1.67 1.67 1.
Citric acid 10 10 10 10 10 10
S.B.C. 10 10 10 10 10 10
Tartaric acid 0 0 0 0 0 0
S.S. Glycolate 0 0 0 3 5 2.
C.C.Na 0 3 5 0 0 2.
Mg. Stearate 1.5 1.5 1.5 1.5 1.5 1.
Flavor 3 3 3 3 3 3
M.C.C. 15 15 15 15 15 15
Tablettose 58.83 55.83 53.83 55.83 53.83 53
Quantities are given as % w/w.
S.B.C, Sodium bicarbonate; S.S. Glycolate, Sodium starch glycolate; C.C
sodium); Mg. Stearate; Magnesium stearate; M.C.C, Micro crystalline ceﬂow and compressibility like bulk density, tapped density, an-
gle of repose, ﬂow ability, compressibility index and Hausner
ratio were determined according to ofﬁcial methods. All deter-
minations were made in triplicate and results were presented as
average ± S.D.
2.2.14. Tablet evaluation
Tablets from each formulation were evaluated (British Phar-
macopoeias, 2008) for various ofﬁcial and unofﬁcial parame-
ters as under.
2.2.15. Physical properties of tablets
Weight variation was calculated after measuring 20 tablets
individually (United States pharmacopoeia (USP 31 NF-26)
and revision, 2008) using a digital balance (Libror AEG-120,
Schimadzu, Japan). The deviation of individual weight from
average weight was calculated and weight variation was
calculated.
The thickness of 10 tablets from each formulation was mea-
sured using a digital tablet tester (Pharma test, Hamburg) and
their average and standard deviation were calculated.
2.2.16. Mechanical strength of tablets
Crushing strength of 10 tablets, from each formulation, was
determined using a digital tablet hardness and thickness testerD-06 ED-07 ED-08 ED-09 ED-10 ED-11 ED-12
67 1.67 1.67 1.67 1.67 1.67 1.67
0 0 0 0 0 0
10 10 10 10 10 10
10 10 10 10 10 10
5 0 0 0 3 5 2.5
5 0 3 5 0 0 2.5
5 1.5 1.5 1.5 1.5 1.5 1.5
3 3 3 3 3 3
15 15 15 15 15 15
.83 58.83 55.83 53.83 55.83 53.83 53.83
.Na, Cross carmellose sodium (cross linked carboxy methyl cellulose
llulose.
Table 4 Evaluation of domperidone as per SeDeM expert
system.
Parameter Results
V ‘‘r’’
Bulk density 0.226 2.26
Tapped density 0.336 3.36
Inter particle porosity 1.45 0
Carr’ index 32.74 6.548
Cohesion Index 66 3.3
Hausner ratio 1.487 7.565
Angle of repose 40 2
Powder ﬂow 0 0
Loss on drying 2.34 7.66
Hygroscopicity 6.39 6.81
Particles < 50 1 9.8
Homogeneity Index 0.014 5.2
V, Experimental values; ‘‘r’’, Converted experimental value.
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Frommean values of crushing strength, diameter thickness, and
tensile strength of tablets and speciﬁc crushing strength of tab-
lets were calculated (Chuan-Yu et al., 2005; De Jong, 1987).
Friability was determined according to ofﬁcial monograph
(British Pharmacopoeias, 2008) using single drum friabilator
(Faisal Engineering, Pakistan).
2.2.17. Drug content
Domperidone content of tablets was determined as per the
ofﬁcial method described in B.P., 2009 (British Pharmacopoe-
ias, 2008) using methanol as solvent and as blank solution.
Absorbance of the sample solution and standard solution
was measured at 284 nm using a double beam UV–visible spec-
trophotometer (Perkin Elmer, USA) (British Pharmacopoeias,
2008). The drug content was calculated by a comparison of
absorbance of two solutions. All determinations were made
in triplicate and their average and standard deviation were
calculated.
2.2.18. Effervescence time of tablets (disintegration time)
Effervescence time was determined as per European pharma-
copeia, by allowing one tablet to disperse completely in
250 ml of puriﬁed water at room temperature (European phar-
macopoeia et al., 2005). Time required for the completion of
effervescence was noted using a digital stopwatch (Sony, Ja-
pan). Effervescence time determination was performed for 6
tablets and results were presented as average ± S.D.
2.2.19. Moisture content
The moisture content of the tablet was determined using a Hal-
ogen moisture analyzer (Mettler Toledo, Switzerland). Pow-
dered tablets were loaded to the pan of moisture analyzer
and loss on drying was recorded. Determination was made
in triplicate and results were presented as average ± S.D.
2.2.20. Wetting time of tablets
Wetting time of the tablets from each formulation was deter-
mined by placing the tablet on a ﬁlter paper soaked in a watch
glass containing 5 ml puriﬁed water. The time required for
complete hydration of the tablet was noted with a digital stop-
watch (Sony, Japan). The experiment was performed in tripli-
cate for each formulation and average waiting time was
calculated (Zade et al., 2009).
2.2.21. Study of effect of different parameters on rate of
effervescence reaction
To study the effect of different parameters on effervescence
time, tablets were prepared from optimized formulation by
varying these parameters as under;
2.2.22. Effect of surface area of the tablet
To study the effect of surface area of the tablet on efferves-
cence time, all formulations were compressed on smaller
punches (10 mm, oval) and larger punches (13 mm round)
and their effervescence time was compared. To minimize the
effect of compressibility on effervescence time, hardness of tab-
lets compressed on smaller punches was such that its tensile
strength and speciﬁc hardness were comparable to those of lar-
ger sized tablets.2.2.23. Effect of super disintegrants
Two super disintegrants (cross linked carboxy methyl cellulose
sodium and sodium starch glycolate) were used to study their
effects on effervescence time of the tablets. Effervescent tablets
were prepared with 20% of effervescent pair and at a hardness
level of 7–10 kg. Disintegrants were added alone (concentra-
tion levels 3% and 5%) and in combination (2.5% w/w each)
and their effervescence time was compared.
2.2.24. Effect of tablet compression force
To study the effect of compressibility on the effervescence time
of the tablets, tablets from optimized formulation were com-
pressed at 3 levels of hardness i.e.
4–7 kg
7–12 kg
12–16 kg
Effervescence time was determined for 6 tablets, from each
level, using 250 ml of puriﬁed water, their average was calcu-
lated and compared with each other. Results were presented
as average ± S.D.
3. Results and discussion
3.1. Evaluation of material as per SeDeM expert system
Domperidone is a white non ﬂowing powder and was evalu-
ated for 12 parameters as per the SeDeM expert system. As
evident from the data given in Table 4, dimension, compress-
ibility, and ﬂow ability/powder ﬂow factors for domperidone
are lower than acceptable values and need to be improved in
order to get tablets by direct compression. Index of good com-
pressibility was calculated for domperidone and was found to
be well below the acceptable limit of 5 (Table 5).
Materials with better ﬂow and compressibility are required
for preparation of their effervescent tablets by direct compres-
sion. Diluents and effervescent pair are the 2 main excipients
that will play their role to overcome deﬁciencies of domperi-
done and making it suitable for direct compression. So diluents
with higher values of the above mentioned factors should be
Table 5 ‘‘r’’ Values of domperidone and excipients as per SeDeM expert system.
Parameter Diluents Eﬀervescent material
M.C. cellulose Tabletose C. acid T. acid S.B.C
Bulk density 3.85 6.1 7.52 9.21 6.8
Tapped density 5.26 7.38 9.17 10 10
Inter particle porosity 5.8 4.33 1.99 0.87 3.92
Carr’ index 5.36 3.47 3.6 1.923 6.4
Cohesion Index 5.65 6.3 5.7 6.6 4.45
Hausner ratio 8.2 8.95 8.9 9.45 7.65
Angle of repose 4.2 5.6 5.8 5.2 3.8
Powder ﬂow 6 7 6.5 6 4
Loss on drying 5.93 9.52 6.28 5.7 7.84
Hygroscopicity 8.29 9.055 8.61 8.395 8.595
Particles < 50 7.41 9.93 9.9 9.86 9.72
Homogeniety Index 6.42 6.3 5.3 5 5.6
Results are presented as ‘‘r’’ value of SeDeM diagram.
M.C. cellulose, micro crystalline cellulose; C. acid, citric acid; T. acid, tartaric acid; S.B.C., sodium bicarbonate.
438 A. Khan et al.selected for the formulation of effervescent domperidone
tablets.
As evident from the results presented in Table 5 and Se-
DeM diagram for micro crystalline cellulose (Fig. 2), most of
the studied parameters of MCC were within the normal range,
i.e. above 5. Only 2 parameters bulk density and angle of re-
pose had ‘‘r’’ values below 5 which resulted in an average
‘‘r’’ value of compressibility factor below the limit.Figure 2 SeDeM diagrams of dom‘‘r’’ Value of angle of repose is also below 5 indicating its
poor ﬂow ability. The ﬂow of MCC will increase with the addi-
tion of lubricants and colloidal silicon dioxide into the formu-
lation. The results of the rest of the parameters prove its
suitability for direct compression.
Comparison of SeDeM proﬁle of 2 diluents shows that they
are suitable for the preparation of ODTs by direct compres-
sion. (Fig. 3) MCC has a lower ‘‘r’’ value of bulk densityperidone and main excipients.
Figure 3 Comparison of tablettose and MCC.
Table 6 Various indices of material as per SeDeM expert
system.
Ingredient I.P. I.P.P. I.G.C.
Domperidone 0.5 4.542 4.324
Micro crystalline cellulose 0.833 6.114 5.821
Tablettose-80 0.833 6.995 6.659
Cross carmellose sodium 0.75 6.319 6.016
Sodium starch glycolate 0.667 6.04 5.75
Citric acid 0.833 6.606 6.289
Tartaric acid 0.833 6.157 6.204
Sodium bicarbonate 0.667 6.565 6.25
I.P, parameter index; I.P.P, parameter index proﬁle; I.G.C, index of
good compressibility.
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on the upper side and expected to cover the shortage. Similarly
tablettose is deﬁcient in both parameters of compressibility
which are very high for MCC and will compensate lower val-
ues of tablettose-80. The rest of the parameters for both are
well above 5 proving that they can be successfully applied to
direct compression. The I.G.C. value of both the diluents
was calculated and found to be well above the acceptable limit.
In combination they will provide an efﬁcient diluent system for
the formulation of ODT by direct compression. On the basis of
SeDeM results of the micro crystalline cellulose and tablettose
(Fig. 3) they will be used in combination as diluents. They will
improve the ﬂow and compressibility of domperidone to the
extent of making it suitable for direct compression.
Citric acid is a crystalline solid (Handbook of Pharmaceu-
tical Excipients and Edition, 2009). To get uniform size pow-
der and increase its surface area, it was pulverized through
mesh number 40 and evaluated for different parameters as
per the SeDeM expert system. As evident from the data pre-
sented in Table 5. Average ‘‘r’’ values for all the factors were
within the normal range of 5–10. Only compressibility factor
has average ‘‘r’’ values lower than 5 indicating its poor com-
pressibility. Two of the parameters (inter particle porosity
and Carr’s index) included in the factor have ‘‘r’’ values below
the limit. The I.G.C. was calculated for citric acid and was
found to be above 5 showing its suitability for use in direct
compression.
Like citric acid, tartaric acid was also pulverized through
mesh number 40. Both citric acid and tartaric acid have almost
similar results. Tartaric acid also had a lower compressibility
factor and the rest of the factor was within the acceptable
range of 5–10. The I.G.C. value of tartaric acid was calculated
to be 6.204. It was above the acceptable limit showing its suit-
ability for direct compression.
Sodium bicarbonate has very poor rheological properties as
evident from the data presented in Table 5. Although its I.G.C.
value was within the acceptable range (Table 6), still it cannot
be used alone in direct compression requiring a large quantity
of excipients with good ﬂow and compressibility for compensa-
tion. Its I.G.C. is high due to the high value of some of the
parameters. Some of its parameters have an ‘‘r’’ value at the
uppermost side (close to 10) while some have values very close
to zero.3.2. Selection of acid to base ratio
Both the acidic moieties (citric acid and tartaric acid) in-
tended to be used in the formulation of effervescent domper-
idone tablets were pulverized through mesh number 40 using
a rotary granulator (STC, China). After pulverization they
were dried at 45 ± 5 C for 1 h to remove absorbed
moisture.
Sodium bicarbonate was heated at 120 C for 30 min. At
elevated temperatures some of sodium bicarbonate is con-
verted into sodium carbonate forming a protective layer and
the surface of sodium bicarbonate gets passive. The surface
passive sodium bicarbonate was used in the formulation of
effervescent tablets.
Quantity of acid and base for effervescence reaction was
calculated on a molar basis of their balanced psychometric
equation. They were allowed to react in puriﬁed water and
the pH of the solution was noted for any remaining acid or
base. The pH of the resultant solution was on the acidic side
showing complete consumption of sodium bicarbonate. The
unreacted citric acid resulted in the acidic pH of the solution
which improved taste perception.
In the case of tartaric acid the pH of the solution was
the alkaline showing the presence of free sodium bicarbon-
ate in the solution. Tartaric acid is highly hygroscopic and
absorbs atmospheric moisture to a greater extent. The high
moisture content reduces tartaric acid quantity per weight.
On that basis tartaric acid was dried properly before inclu-
sion into the formulation and its quantity was also slightly
more than that required for neutralization of sodium
bicarbonate.
3.3. Determination of effervescent pair quantity per tablet
As shown in Table 7, very small disintegration time can be
achieved with effervescent material constituting 30% w/w of
the total tablet weight (57.83 ± 3.06 s). Still effervescent mate-
rial is not included in this concentration because;
 Sodium bicarbonate has very poor compressibility and rhe-
ological properties [20]. Its high concentration can affect the
ﬁnal product adversely.
 The difference between disintegration time with 20% w/w
and 30% w/w effervescent material is very low.
Table 7 Disintegration (effervescence) time v/s quantity of effervescent material.
Qty of acid/base pair (%) ET-01 ET-02 ET-03 ET-04 ET-05 ET-06 Avg. E.T. Std. Dev.
10 137 141 132 139 134 129 135.33 4.502
20 68 77 71 64 74 69 70.5 4.594
30 59 56 54 61 53 58 56.833 3.061
E.T., effervescence time (Second); Avg. E.T., average effervescence time; Std. Dev., standard deviation.
440 A. Khan et al.Due to these reasons effervescent material was included in
the formulation of effervescent tablets in 20% w/w of the total
weight of the tablet. Same ratio was applied for citric acid/so-
dium bicarbonate and tartaric acid/sodium bicarbonate pairs.
3.4. Taste evaluation
The taste making agent combination was composed of a sweet-
ening agent (aspartame) and ﬂavor (tutti fruity). As evident
from the volunteer’s response (Table 8) formulation without
any taste making agent (sweetener and ﬂavor) had an accept-
able taste because domperidone is a tasteless material. The
taste of the other formulation ingredients was dominated by
an acidic taste of citric acid. Quantity of citric acid was slightly
more than that required for neutralization of sodium bicarbon-
ate on the basis of stoichiometric calculations. On the basis of
the volunteer’s response, the taste making agent was included
into the formulation at the level of 3% as at this concentration
the taste was marked as pleasantly sweet. A concentration of
4% and 5% of the taste making agent was ranked as strongly
sweet by most of the volunteers.
3.5. Evaluation of powder blend
Tablettose-80 and micro crystalline cellulose were collectively
used as diluents on the basis of their SeDeM proﬁle. Due to
their good ﬂow and compressibility both of these excipients
were able to compensate the poor ﬂow and compressibility
of domperidone and other excipients in the formulation (e.g.
Sodium bicarbonate). It is evident from Table 9, that all for-
mulations have a very good Hausner ratio, Carr index and an-
gle of response. Angle of repose for all formulations was less
than 31. ED-12 showed the angle of repose to be worst of
all formulations even then it was on the good side. There
was a little bit variation among different formulations due to
changes in the proportion of tablettose as it was replaced withTable 8 Volunteers’ response about taste.
Formulation Number of volunteers rated tablets as
0 1 2 3 4
TEF-01 – 8 – – –
TEF-02 – 3 4 1 –
TEF-03 – – 7 1 –
TEF-04 – – 1 7 –
TEF-05 – – – 3 5
TEF-06 – – – – 8
0, Bitter tasting; 1, Acceptable; 2, Pleasant; 3, Sweet; 4, Strongly
sweet.other excipients having low ﬂow ability. Good ﬂow character-
istics have been conﬁrmed by ﬂow of granules from hopper
during compression and a narrow range of weight variation
in compressed tablets. The whole powder blend for all formu-
lations was free ﬂowing (angle of repose less than 32, Hausner
ratio below 1.15 and Carr’s index less than 12.01). During
compression ﬂow of the granules was uniform and a very
low weight variation was observed in compressed tablets.
Lubrication of the granules was very good as the surface of
the tablets from all batches was smooth and shiny.
3.6. Tablet evaluation
Physically tablets from all the batches were very elegant. Their
surface was smooth and shiny without sticking and picking
indicating proper lubrication of powder blend. Theoretically
weight per tablet was 600 mg with allowed ofﬁcial variation
±5% (British Pharmacopoeias, 2008). Weight variation was
very low i.e. less than ±3.5% for all the formulations. The
highest weight variation was observed in the case of ED-12
which was ±3.4%. It is well within the ofﬁcial range. Rest
of all the formulations showed a weight variation less than
±3.4%. It indicates that the ﬂow of the granules was very efﬁ-
cient and uniform.
Thickness of the tablets from all formulations was within
the range of 3.5–3.8 mm. No signiﬁcant variation was observed
in the thickness of tablets from different formulation.
Friability of the tablets from all the formulations was with-
in the ofﬁcial limits (British Pharmacopoeias, 2008) that was
less than 0.8%. It was the highest for ED-02 and ED-08 and
was 0.45% while for the rest of the formulations it was evenFigure 4 Effervescence time of tablets.
Table 9 Evaluation of powder blend.
Property ED-01 ED-02 ED-03 ED-04 ED-05 ED-06 ED-07 ED-08 E -09 ED-10 ED-11 ED-12
Volume bulk 30 ± 0.87 30 ± 0.79 30 ± 1.0 30 ± 1.0 30 ± 0.76 30 ± 0.57 30 ± 0.88 30 ± 0.60 30 ± 0.80 30 ± 0.78 30 ± 0.5 30 ± 0.8
Volume tapped 27.75 ± 0.46 27.5 ± 0.5 27 ± 0.42 27.4 ± 0.69 27.1 ± 0.7 27 ± 1.0 27.8 ± 0.4 27.15 ± 0.77 6.8 ± 0.45 27.2 ± 0.84 27.6 ± 0.63 26.8 ± 0.49
Bulk density 0.833 ± 0.02 0.833 ± 0.03 0.832 ± 0.02 0.833 ± 0.04 0.826 ± 0.08 0.83 ± 0.06 0.833 ± 0.04 0.833 ± 0.08 0 38 ± 0.05 0.836 ± 0.04 0.836 ± 0.07 0.833 ± 0.08
Tapped density 0.901 ± 0.05 0.909 ± 0.03 0.924 ± 0.07 0.912 ± 0.05 0.915 ± 0.03 0.922 ± 0.02 0.899 ± 0.03 0.921 ± 0.01 0 33 ± 0.02 0.923 ± 0.06 0.909 ± 0.01 0.933 ± 0.04
Hausner ratio 1.082 1.091 1.11 1.095 1.078 1.111 1.079 1.106 113 1.104 1.087 1.104
Carr’s index 8.163 9.213 11.058 9.484 10.775 11.084 7.923 10.564 1 336 10.407 8.732 12.005
h Repose 23.802 ± 0.5 26.41 ± 0.28 28.96 ± 0.07 27.12 ± 0.13 29.46 ± 0.1 28.59 ± 0.2 21.94 ± 0.18 28.73 ± 0.2 2 .81 ± 0.2 28.77 ± 0.1 23.63 ± 0.17 30.21 ± 0.3
Results presented as average ± standard deviation (n= 3).
h Repose, angle of repose.
Hausner ratio and Carr’ index were calculated from average bulk density and average tapped density of each formulation.
Table 10 Tablets evaluation.
Property ED-01 ED-02 ED-03 ED-04 ED-05 ED-06 ED-07 ED-08 -09 ED-10 ED-11 ED-12
Crushing strength 9.201 ± 1.5 8.61 ± 1.8 6.675 ± 1.7 7.055 ± 1.4 6.543 ± 0.9 8.64 ± 1.2 9.15 ± 1.8 8.931 ± 1.67 354 ± 1.38 8.422 ± 1.7 7.13 ± 1.3 7.25 ± 1.83
Tensile strength 0.123 0.113 0.087 0.093 0.087 0.117 0.124 0.121 .127 0.114 0.098 0.099
Friability 0.3 ± 0.15 0.45 ± 0.15 0.15 ± 0.1 0.15 ± 0.15 0.15 ± 0.1 0.3 ± 0.15 0.3 ± 0.15 0.45 ± 0.1 0.3 ± 0.15 0.3 ± 0.15 0.3 ± 0.15 0.3 ± 0.15
Eﬀervescence time 87 ± 3 71 ± 4 54 ± 2 63 ± 5 32 ± 5 43 ± 3 75 ± 5 63 ± 5 52 ± 4 49 ± 4 29 ± 5 41 ± 3
Weight variation ±02 ±02 ±03 ±02.5 ±03 ±03 ±02.5 ±02.6 ±02.8 ±02.5 ±02 ±3.4
Moisture content 1.79 ± 0.2 1.57 ± 0.5 1.49 ± 0.4 1.36 ± 0.08 1.42 ± 0.07 1.77 ± 0.09 1.83 ± 0.06 1.61 ± 0.1 .73 ± 0.09 1.47 ± 0.2 1.3 ± 0.26 1.8 ± 0.1
Wetting time 181 ± 3 170 ± 3 166 ± 4 150 ± 3 146 ± 2 150 ± 4 192 ± 3 176 ± 2 184 ± 3 168 ± 2 150 ± 2 159 ± 3
Drug content 97.35 ± 0.93 101.19 ± 0.37 99.72 ± 1.03 100.53 ± 0.87 98.11 ± 0.96 97.26 ± 0.8 99.67 ± 1.06 98.42 ± 1.1 7.9 ± 0.78 99.32 ± 0.99 101.76 ± 0.89 98.79 ± 1.17
Results are presented as average ± standard deviation.
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Figure 5 Effect of surface area on effervescence time.
Table 11 Effect of tablet surface area on effervescence time of the tablet.
Batch No. Eﬀervescence Time (s) % Increase in eﬀervescence time
Large punch Small punch
ED-01 78 163 2008.97
ED-02 54 126 233.33
ED-03 71 137 192.96
ED-04 63 142 225.4
ED-05 32 98 306.25
ED-06 53 112 211.32
ED-07 52 119 228.85
ED-08 44 97 220.45
ED-09 75 153 204
ED-10 49 112 228.57
ED-11 29 87 300
ED-12 41 102 248.78
E. Time, effervescence time.
Table 12 Comparison between mechanical properties of tablets compressed on larger (13 mm) and smaller (10 mm) punch.
Batch No. Larger punch size (13 mm) Smaller punch size (10 mm)
K (kg) T (mm) D (mm) T.S. s K (kg) T (mm) D (mm) s T.S.
ED-01 9.201 3.65 13 0.123 0.194 7.14 3.5 10 0.204 0.13
ED-02 8.61 3.72 13 0.113 0.178 6.67 3.45 10 0.193 0.123
ED-03 6.675 3.75 13 0.087 0.137 5.35 3.45 10 0.155 0.099
ED-04 7.055 3.7 13 0.093 0.147 5.78 3.6 10 0.161 0.102
ED-05 6.543 3.65 13 0.087 0.138 5.52 3.55 10 0.155 0.099
ED-06 8.64 3.6 13 0.117 0.185 6.99 3.5 10 0.2 0.127
ED-07 9.15 3.61 13 0.124 0.195 7.47 3.6 10 0.208 0.132
ED-08 8.931 3.6 13 0.121 0.191 7.58 3.5 10 0.217 0.138
ED-09 9.354 3.6 13 0.127 0.199 7.5 3.55 10 0.211 0.134
ED-10 8.422 3.6 13 0.114 0.18 6.65 3.46 10 0.192 0.122
ED-11 7.132 3.55 13 0.098 0.154 5.99 3.5 10 0.171 0.109
ED-12 7.249 3.58 13 0.099 0.156 5.9 3.48 10 0.17 0.108
K, compression force; T, tablet thickness; D, tablet diameter; T.S., tensile strength of tablet; s, speciﬁc hardness of tablets.
442 A. Khan et al.below 0.45% (in the range of 0.15–0.3%). No edging was ob-
served in tablets from any formulation. Low friability showed
good mechanical resistance of the tablets.
Crushing strengths of the tablets were in the range of 6–
10 kg. It is evident from Table 2 that the hardness of the tablet
increases with increase in the percentage of tablets. It was the
highest for ED-09 which was 9.354 (n= 10) containing56.83% of tablettose. Its tablettose content was less than
ED-01, ED-02, ED-08, and ED-10. Even then its hardness
was more than the rest of the formulation and its friability
was just 0.3%. As a whole tablets from all the formulations
were hard enough to withstand handling during processing.
The drug content of all the formulations was within the
range of 97–102%, as in Table 10, which was within the ofﬁcial
limits i.e. 95–105% (British Pharmacopoeias, 2008). These re-
sults of the drug content showed that the drug has been uni-
formly blended with excipients.
The surface of the tablets was not prone to premature effer-
vescence. As percentage of acid–base pair in tablets was rea-
sonable (20% w/w) they have been uniformly mixed with the
rest of the excipients after pulverization into a ﬁne particle size.
Reduction in particle size caused increased surface area which
leads to a better and quicker reaction between acid and base
when exposed to water.
The moisture content of all formulations was within the
range of 1.3–1.8%. It was not high enough to cause any pre-
mature effervescence. A higher moisture content was observed
for ED-12 which was 1.8%.
Effervescence time of all formulations has been presented in
Fig. 4. Effervescence time of the tablet containing only citric
acid and sodium bicarbonate (ED-01) was 78 s (n= 6). Effer-
vescence reaction was very slow and gradual while the efferves-
Table 13 Effect of tablet hardness on tablet effervescent reaction.
Parameter (Unit) Level-1 Level-2 Level-3
Average hardness (kg) 5.68 ± 0.49 9.21 ± 1.27 12.34 ± 0.85
Weight (mg) 607.52 ± 1.36a 603.86 ± 1.4a 604.37 ± 1.51a
Thickness (mm) 3.93 ± 0.074 3.70 ± 0.059 3.61 ± 0.063
Eﬀervescence time (s) 38 ± 4 45 ± 3 52 ± 3
Results are presented as average ± standard deviation.
Level-1, 4–7 kg; Level-2, 7–12 kg; Level-3, 12–14 kg.
a Weight variation (%).
Application of SeDeM Expert system in formulation development of effervescent tablets by direct compression 443cence time of the tablet containing tartaric acid and sodium
bicarbonate, in the same concentration, alone without any
super disintegrant, was 52 s (ED-07). It proved that reaction
between citric acid and sodium bicarbonate was slower as com-
pared to reaction between tartaric acid and sodium
bicarbonate.
3.7. Effect of tablet surface area on disintegration time of tablet
A decrease in surface area available for effervescence reaction
resulted in a large increase in effervescence time of all formu-
lations, irrespective of acid base pair and super disintegrant
added to the formulation as presented in Table 11. An impor-
tant factor which can affect effervescence time is compression
of the tablet. This factor was nulliﬁed by compressing two
sized tablets under similar tensile strength and speciﬁc hard-
ness (De Jong, 1987). Hardness of the small sized tablet was
kept in the range of 5–7.5 kg as evident from Table 12. At this
hardness their tensile strength and speciﬁc hardness were al-
most same as those of the larger sized tablets (f2 = 99.5 for
all formulations). An increase in effervescence time due to a
larger surface area was in the range of 192.96–307%, as given
in the Table 11. The highest increase was observed with ED-11
which was 306.25% of the effervescence time of tablets with a
large surface area. The smallest was 192.96% with ED-03. The
rest of the increase in disintegration time was in between these
two values. It is evident from Table 11, that decreasing the tab-
let size caused a huge increase in effervescence time of tablets.
A comparison of disintegration time of both sized tablets has
been graphically presented in Fig. 5.
3.8. Effect of disintegrant on effervescence time of tablets
When disintegrant was added along with an acid/base pair, it
enhanced effervescence reaction. It was much more vigorous
as compared to that without disintegrant. Tablet moved up
and down during the whole of the effervescent reaction.
Cross carmellose sodium acted as a wicking agent increasing
water penetration into the inner core of the tablets (Hand-
book of Pharmaceutical Excipients and Edition, 2009). The
acid/base pair got exposed to water quickly and the rate of
the effervescent reaction was enhanced. In a higher concen-
tration cross carmellose sodium absorbed water and formed
a gel like material. The core of the tablet remained intact
and the inner portion of the tablet got slowly exposed
to water and the rate of effervescence reaction got reduced.
It indicated that cross carmellose sodium was efﬁcient
at low concentration (3%, w/w) as compared to the high
percentage (5%, w/w).SSG produced a concentration dependent decrease in effer-
vescence time with both CA/SBC and TA/SBC pairs. At lower
concentrations (3% w/w) a drop in disintegration time by SSG
was smaller than that caused by the same concentration of
cross carmellose sodium. But at a higher concentration (5%
w/w), SSG was more efﬁcient than cross carmellose sodium.
A drop in disintegration time by SSG at a higher concentration
was larger than the drop caused by cross carmellose sodium
with both acid/base pairs.
3.9. Effect of tablet compression force
Compression force has a negligible effect on the effervescence
time of the tablet as evident from the data presented in Ta-
ble 13. When the tablet breaks down during effervescence reac-
tion, the surface area available for effervescence reaction
increases resulting in its enhanced rate. By increasing the
crushing strength of the tablet, water penetration into the tab-
let reduces but as the effervescence reaction starts, it moves
into the tablet’s core layer by layer, overcoming the hard tablet
core. As effervescent tablets contain very low moisture they are
very much prone to capping and edging at a higher level of
compression force.4. Conclusion
It is concluded from the study that the SeDeM expert sys-
tem can be successfully applied for the prediction of suit-
ability of material for direct compression. It gives accurate
predictions about material behavior and response of the
material was same as predicted by the SeDeM expert sys-
tem. It provides information about shortcoming of the
material to be processed by direct compression which can
be rectiﬁed at a pre formulation level to get a robust for-
mulation that can be easily scaled up for commercial man-
ufacturing. The SeDeM expert system also reduces the
number of trials at a pre formulation level to get produced
by direct compression especially in the case of a high drug
load. By developing a database of the excipients commonly
used in pharmaceutical formulation, the material of the de-
sired characteristics can be selected with particular
characteristics.
Effervescent tablets are highly moisture sensitive and even
a trace amount of water can result in complete deterioration
of the product. Direct compression is the most preferable
method for the preparation of effervescent tablets. By apply-
ing the SeDeM expert system in the formulation of efferves-
cent tablets, commercial manufacturing of the dosage form
will become very economical and time saving.
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